AAAAAA

   
Results: 1-13 |
Results: 13
Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression
Authors: Rabaud, C Charreau, I Izard, S Raffi, F Meiffredy, V Leport, C Guillemin, F Yeni, P Aboulker, JP
Citation: C. Rabaud et al., Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression, SC J IN DIS, 33(10), 2001, pp. 759-764
Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial
Authors: Aboulker, JP Babiker, A Darbyshire, JH Debre, M Giaquinto, C Gibb, DM Harper, L Newberry, A Saidi, Y Levy, J Della Negra, M Forbes, J Vaudry, W Mechinaud, F Nicolas, J Wahn, V Dammann, C Notheis, G Hinkelmann, B Butler, K Giaquinto, C De Manzini, A Mazza, A Duse, M Loy, A Plebani, A Castelli-Gattinara, G Cellini, M Palomba, E Caselli, D Guarino, A Osimani, P Scherpbier, H Delgado, A Gomez, ID Lecuona, JE Pena, MJM Baselga, C Leal, JAL Amador, JTR Canosa, C Sierra, AM Calavia, LC Rodrigo, C Guasch, CF Bohlin, A Nadal, D Mok, J Lyall, H Novelli, V Sharland, M Sloper, K
Citation: Jp. Aboulker et al., Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial, ARCH DIS CH, 84(3), 2001, pp. 230-236
Viral load in treatment with antiretroviral therapy and interleukin 2
Authors: Aboulker, JP
Citation: Jp. Aboulker, Viral load in treatment with antiretroviral therapy and interleukin 2, J AM MED A, 284(16), 2000, pp. 2055-2055
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
Authors: Descamps, D Flandre, P Calvez, V Peytavin, G Meiffredy, V Collin, G Delaugerre, C Robert-Delmas, S Bazin, B Aboulker, JP Pialoux, G Raffi, F Brun-Vezinet, F
Citation: D. Descamps et al., Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, J AM MED A, 283(2), 2000, pp. 205-211
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study
Authors: Masquelier, B Descamps, D Carriere, I Ferchal, F Collin, G Denayrolles, M Ruffault, A Chanzy, B Izopet, J Buffet-Janvresse, C Schmitt, MP Race, E Fleury, HJA Aboulker, JP Yeni, P Brun-Vezinet, F
Citation: B. Masquelier et al., Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study, ANTIVIR TH, 4(2), 1999, pp. 69-77
Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia
Authors: Salmon-Ceron, D Fillet, AM Aboulker, JP Gerard, L Houhou, N Carriere, I Ostinelli, J Vilde, JL Brun-Vezinet, F Leport, C
Citation: D. Salmon-ceron et al., Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia, CLIN INF D, 28(4), 1999, pp. 901-905
Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis
Authors: Raffi, F Franck, J Pelloux, H Derouin, F Reliquet, V Ambroise-Thomas, P Aboulker, JP Leport, C Dumon, H
Citation: F. Raffi et al., Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis, DIAG MICR I, 34(1), 1999, pp. 51-56
An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome
Authors: Aboulker, JP Babiker, AG Flandre, P Gazzard, B Loveday, C Nunn, AJ Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schurrman, R Brun-Vezinet, F Descamps, D Jeffries, D Tedder, R Weber, J Darbyshire, JH Reiss, P Weverling, G
Citation: Jp. Aboulker et al., An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome, AIDS, 13(5), 1999, pp. 565-573
Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2
Authors: Zou, WP Foussat, A Houhou, S Durand-Gasselin, I Dulioust, A Bouchet, L Galanaud, P Levy, Y Emilie, D Aboulker, JP Capitant, C Boue, F Bouvet, E Karmochkinc, M Kazatchkine, M Oksenhendler, E Viard, JP Weiss, L Yeni, P Delfraissy, JF Goujard, C Jarrousse, B Lepeu, G Cartier, F Bazin, C Six, M Gastaut, JA Seligmann, M Herrerra, A Maral, J
Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463
HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study
Authors: Aboulker, JP Babiker, AG Brun-Vezinet, F Darbyshire, JH Flandre, P Gazzard, B Nunn, AJ Goodall, R Aber, V Bragman, K Breckenridge, AM Carbon, C Charreau, I Chene, G Collis, P Cooper, D Dormont, J Fiddian, P Flepp, M Goebel, FD Hooker, M Lange, J Luthy, R Peto, TEA Reiss, P Seligmann, M Stone, AB Thomis, J Vella, S Walckenaer, G Warrell, D Weller, IVD Wilber, R Yeni, P Yeo, J Withnall, R Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schuurman, R Descamps, D Jeffries, D Tedder, R Weber, J Krzyanowski, C Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65
Drug-resistant genotyping in HIV-1 therapy
Authors: Aboulker, JP
Citation: Jp. Aboulker, Drug-resistant genotyping in HIV-1 therapy, LANCET, 354(9184), 1999, pp. 1120-1120
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial
Authors: Levy, Y Capitant, C Houhou, S Carriere, I Viard, JP Goujard, C Gastaut, JA Oksenhendler, E Boumsell, L Gomard, E Rabian, C Weiss, L Guillet, JG Delfraissy, JF Aboulker, JP Seligmann, M
Citation: Y. Levy et al., Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, LANCET, 353(9168), 1999, pp. 1923-1929
Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial
Authors: Parazzini, F Ricci, E Di Cintio, E Chiaffarino, F Pardi, G Parazzini, F Bortolus, R D'Oro, LC Biraghi, P Bucceri, A Ravizza, M Grossi, E Muggiasca, ML Tibaldi, C Prati, A Iasci, A Aronica, E Ceccarelli, E Frigerio, L Borlone, P Stagnizza, M Agnoletto, V Tognoni, G Lazzrin, A Massobrio, M Garzetti, GG Ciavattini, A Mosca, S Greco, P Vimercati, A Guerra, B Bianchi, S Bovicelli, L Prati, E Innocenti, TA Fiscella, A Bucceri, A Grossi, E Rossi, G Rancilio, L Ferraris, G Vignali, M Muggiasca, ML Semprini, AE Ravizza, M Castagna, C Della Torre, M Martinelli, P Sansone, M di Lenardo, L Russolo, A Rubino, E Lo Bue, G Maccabruni, A Arlandi, L Citernesi, A Villa, P Mancuso, S Pachi, A Scaravelli, G Tibaldi, C Benedetto, C Ziarati, N Gabiano, C Alberico, S Franchi, M Zanconato, G Fedele, L Newell, ML Bailey, A Peckham, C Darbyshire, J Sanchez, E Semprini, AE Leyes, M Ciria, LM Coll, O Fortuny, C Bogunya, JM Paya, A Mur, A Casellas, M Lain, J Anzen, B Lindgren, S Rudin, C Irion, O Bewley, S Kennedy, J Mandelbrot, L Bazin, B Aboulker, JP Crenn-Hebert, C Tudal, CF Bech, A Lobut, R Chemla, JP Milliez, J Courpotin, C Mandelbrot, L Firtion, G Benifla, JL Ottenwalter, A Vilmer, E Hocke, C Douard, D Berrebi, A Tricoire, J Pauly, I Le Lorier, B Bongain, A Monpoux, F Cravello, L Perrimond, H Newell, ML Darbyshire, J Peckham, C Coll, O Sanchez, E Mandelbrot, L Aboulker, JP Bazin, B Blanche, S
Citation: F. Parazzini et al., Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial, LANCET, 353(9158), 1999, pp. 1035-1039
Risultati: 1-13 |